We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $163M
1-Year Est. Return 240.43%
This Fund
S&P 500
This Quarter Est. Return
-27.96%
1 Year Est. Return
+240.43%
3 Year Est. Return
+409.28%
5 Year Est. Return
+142.09%
10 Year Est. Return
+4,071.98%
AUM
$60.2M
AUM Growth
-$26.5M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLUE icon
1
Monte Rosa Therapeutics
GLUE
$1.2B
$26.2M 43.56%
5,652,922
– –
CRSP icon
2
CRISPR Therapeutics
CRSP
$5.12B
$17M 28.18%
498,558
– –
CTNM
3
Contineum Therapeutics
CTNM
$558M
$6.41M 10.64%
918,163
– –
SKYE icon
4
Skye Bioscience
SKYE
$9.03M
$3.19M 5.3%
250,963
– –
RPTX
5
DELISTED
Repare Therapeutics
RPTX
$2.61M 4.33%
2,646,657
– –
TPST icon
6
Tempest Therapeutics
TPST
$13M
$2.59M 4.3%
269,773
– –
ADVM
7
DELISTED
Adverum Biotechnologies
ADVM
$2.21M 3.68%
506,821
– –

Similar funds

TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GF
Gimbal Financial Carmel, Indiana $163M AUM
ACM
Arrington Capital Management Miami, Florida $163M AUM
KFS
Krane Financial Solutions Calabasas, California $162M AUM
VB
Value Base Tel Aviv, Israel $162M AUM 2.31% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $162M AUM
CCM
Candelo Capital Management New York $162M AUM 112.87% 1-Year Est. Return
GCM
Generation Capital Management Pittsford, New York $163M AUM 42.22% 1-Year Est. Return

Versant Venture Management's Q1 2025 Portfolio in Review

As of Q1 2025, Versant Venture Management held 7 positions worth $60.2M, down 31% from $86.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management's ten largest holdings make up 100% of its $60.2M portfolio in Q1 2025.
  • Versant Venture Management opened 0 new positions and closed 0 in Q1 2025.
  • Versant Venture Management's portfolio value fell 31% quarter-over-quarter to $60.2M.

Based on Versant Venture Management's 13F filing for Q1 2025, filed 7 May 2025.